Redox in macrophages · Adaptive redox regulation in inflammatory macrophages
Horizon Europe — Marie Skłodowska-Curie Actions
- Duration
- 2022-09-01 → 2024-08-31
- EU contribution
- €173,847
- Participants
- 1
- Scheme
- HORIZON-TMA-MSCA-PF-EF
Lines connect the coordinator with its partners.
Results in brief
Adaptive redox regulation in inflammatory macrophages
Macrophages are an essential part of the innate immune system. Macrophages have diverse function that include clearing billions of dead cells each day, identifying and killing invading pathogens and initiating and terminating immune responses. They are first responders to pathogens, but also detect and eliminate cancer cells and maintain homeostasis by orchestrating the temporal progression of the wound healing response. We know now that macrophage functions are dictated by their underlying metabolic programs and metabolic adaptability that frequently center on electron transfer reactions (i.e., redox metabolism). For example, macrophages oxidize arginine to generate nitric oxide for pathogen defense; re-routing arginine for this purpose causes substantial changes to overall amino acid metabolism not observed in other cell types. Importantly, the cellular balance of redox reactions is particularly important to prevent cell death by ferroptosis. Ferroptosis is triggered by the accumulation of free Fe2+ iron and excessive free radicals (e.g., as needed for pathogen killing), leading to peroxidation of lipids in the cell membrane and ultimately cell death. Several antioxidant systems work in combination to clear free radicals and thus prevent ferroptosis. These include the glutathione pathway as well as glutathione independent biopterin and ubiquinone pathways and extracellular production of indoles from amino acids. While these redox pathways were discovered in cancer cells, their function and regulation in macrophages (which are major producers of free radicals) was unknown at the start of this project. To address this knowledge gap, this MSCA project used reduced complexity in vitro models of macrophage activation states to answer a) which molecular pathways regulate redox adaptation in different macrophage activation states (i.e. inflammatory, chronic-inflammatory, homeostatic) and b) how macrophages can rewire their redox systems in activation compared to homeostasis.
Data: CORDIS, © European Union
Project objective
Macrophages are key players of the innate immune system and as such maintain homeostasis, initiate inflammatory and redox responses for pathogen defence, but also regulate resolution of inflammation. Supporting these functions are distinct metabolic programmes, which underlie macrophage functional phenotypes. While recent advances have improved the understanding of macrophage metabolic programmes supporting specific activation states, it remains unclear how the redox system is regulated in macrophage activation states and during pathogen defence. Here, I propose to investigate how redox adaptation is regulated during macrophage activation and its impact on functional phenotypes. I will focus on the following three aims: Firstly, I will quantify expression of cystine transporter SLC7A11, which, by importing cystine supports glutathione and coenzyme A synthesis. This will allow a better understanding of the role of cysteine during redox adaptation in comparison to the well-known heme oxygenase 1 (HO-1). Secondly, I will disrupt key regulators of redox adaptation, including SLC7A11 and HO-1 to investigate their effect on macrophage functional phenotype. This will identify key nodes for redox adaptation in different macrophage activation states. Thirdly, I will investigate the temporal profile of electrophilic stress and redox adaptation in response to macrophage activation and during bacterial infection. Overall, this project will contribute to the detailed understanding of redox adaptation during macrophage activation, which is essential for pathogen defence and protection from oxidative stress. Furthermore, identification of new drug targets for redox regulation in macrophages would provide the basis for novel therapies for oxidative stress induced pathologies.
Original text from CORDIS.
Participants
- MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV · MUNCHENCoordinatorGermany
Links
- View on CORDIS
- DOI: 10.3030/101062335
- https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e502593666&appId=PPGMS
- https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5025947da&appId=PPGMS
- https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e510972bc0&appId=PPGMS
Data: CORDIS, © European Union
